Sunshine Biopharma, Inc.
SBFM
$1.55
-$0.04-2.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.03M | -5.13M | -4.23M | -3.68M | -4.09M |
| Total Depreciation and Amortization | 245.70K | 223.50K | 200.50K | 173.10K | 157.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00 | 12.00K | 12.40K | 12.00K | 12.00K |
| Change in Net Operating Assets | -6.28M | -7.63M | -7.80M | -7.42M | -6.19M |
| Cash from Operations | -11.06M | -12.53M | -11.81M | -10.91M | -10.11M |
| Capital Expenditure | -1.60M | -1.66M | -1.17M | -664.60K | -145.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -300.00 |
| Cash Acquisitions | -- | -- | -- | -- | 1.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -226.50K | -663.80K | -886.50K | -796.60K | -1.03M |
| Cash from Investing | -1.83M | -2.32M | -2.06M | -1.46M | -1.18M |
| Total Debt Issued | 347.90K | 347.90K | -- | -- | -- |
| Total Debt Repaid | 12.40K | 0.00 | -120.80K | -120.40K | -124.20K |
| Issuance of Common Stock | 3.87M | 12.08M | 10.47M | 8.57M | 12.66M |
| Repurchase of Common Stock | 0.00 | -3.14M | -3.14M | -3.17M | -3.17M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.23M | 9.29M | 7.21M | 5.28M | 9.36M |
| Foreign Exchange rate Adjustments | -651.10K | -1.04M | 27.60K | -1.13M | 66.60K |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -9.31M | -6.61M | -6.64M | -8.22M | -1.86M |